Skip to content

Clinical trials

Fibrosis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Country / region: South Korea Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20083
20111
20133
20142
20151
20165
20173
20193
20201
20211
20224
20232
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status13
Active, not recruiting4
Terminated4
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital9
Korea University4
89bio, Inc.2
Intercept Pharmaceuticals2
Sang Gyune Kim2
AbbVie1
Asan Medical Center1
Azienda Ospedaliera di Padova1
Bayer1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis38
Liver Cirrhosis5
Esophageal Diseases4
Fatty Liver4
Varicose Veins4
Hepatitis B, Chronic3
Liver Diseases3
Non-alcoholic Fatty Liver Disease3
Ascites2
Carcinoma, Hepatocellular2

Trials

Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.